More than 16 years ago, Cerebrum published an essay by Leon Cooper, Nobel prize-winning physicist and a member of the executive committee of the Dana Alliance for Brain Initiatives, on the monetary state of the field then, called “Scientific Research: Who Benefits? Who Pays?” Has anything changed?
In 1998, the annual direct and indirect costs of brain-related illnesses in the U.S. was estimated at $600 billion, writes Cooper. The figure now is $760 billion; worldwide, the WHO has estimated costs at $3 trillion and increasing. Continue reading
Too many of us live by the catchphrase, “sleep when you’re dead.” When it feels like there is more to do than the day allows, we surrender our sleep hours and then make up for it by consuming an excessive amount of caffeine the next day. After a few days, we’re so exhausted that we can hardly hold our heads up.
May is national “Healthy Vision Month,” so we spoke with Emily Chew, M.D. from the National Eye Institute (NEI) to learn more about visual impairment and what we can do to prevent it. As deputy clinical
director, Chew works one-on-one with patients and conducts research in diabetic eye disease and age-related eye diseases, among other ocular diseases. Continue reading
This Tuesday, May 12, join us on Capitol Hill for a public luncheon briefing about marijuana and the brain. Top experts in the
field will speak about medicinal marijuana and the drug’s effect on the brain, as well as research on the impact of state marijuana policies.